Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic ...
Apr 23, 2015
0
5
Hospitalized heart failure patients given an investigational drug had improved symptoms and other clinical benefits including fewer deaths, than those given standard of care plus a placebo, according to late-breaking clinical ...
Nov 7, 2012
0
0
US federal health inspectors said Monday they have uncovered serious problems at a second Massachusetts pharmacy run by some of the same people whose tainted drugs caused a deadly meningitis outbreak.
Nov 12, 2012
0
0
A new publication in Science Advances from researchers at Karolinska Institutet shows how to use a specific cancer trait to improve treatment of pancreatic tumors.
Nov 1, 2023
0
37
Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found. Their study, published online in the ...
Mar 7, 2014
0
0
A new study conducted by a group of researchers, including the interim executive director of the University of Kentucky Center for Research on Violence Against Women (CRVAW), has found that people who experience interpersonal ...
Jul 19, 2023
0
2
Results of a major HIV prevention trial suggest that daily use of a product – whether a vaginal gel or an oral tablet – does not appear to be the right approach for preventing HIV in young, unmarried African women.
Mar 4, 2013
0
0
The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant region (Fc) of ...
Jan 9, 2014
0
0
Trouble continues for Abbott Laboratories, which shut down an infant formula plant last year amid reported illnesses.
Jan 23, 2023
0
2
Norway said on Friday it would extend its suspension of AstraZeneca's COVID-19 vaccine until April 15 to allow more time to investigate a potential link to severe blood clotting.
Mar 26, 2021
0
4
